• Eka Ventures sees investment opportunities in AI healthcare safety systems as regulatory complexity, deployment growth and potential patient harm increase demand.
• Safely delivering regulated care opens an estimated $8.2 trillion healthcare services market, compared with $311 billion in healthcare and life sciences technology spending.
• The FDA authorized 335 AI-enabled medical devices in 2025, versus 114 in 2020; its September 2026 list contained 1,614 devices.
• Continuous updates to AI medical devices create demand for ongoing safety monitoring and independent verification infrastructure.
• Investment priorities include independent evaluation, regulatory compliance and post-deployment monitoring tools for healthcare providers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eka Ventures LLP published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.